The L’Oréal Group today announced that it has completed the acquisition of Lactobio, a leading probiotic and microbiome research company based in Copenhagen, Denmark.
“The strategic acquisition builds on 20 years of advanced research by L’Oréal into the microbiome scientific territory, deepening its knowledge of the microorganisms that live on the skin’s surface and reinforcing the Groupe’s leadership in this field. The acquisition also opens up new scientific opportunities, including leveraging Lactobio’s microbiome expertise and significant IP portfolio to develop safe and effective new cosmetic solutions using live bacteria,” said the French beauty giant in a statement.
Cosmetic formulations containing live bacteria
Lactobio was founded in 2017 by Søren Kjærulff, Ph.D. and Charlotte Vedel, Ph.D., who developed a proprietary microbiome discovery platform and screening method to select the most effective and safe strains. These precision probiotics, created from a large biobank of lactobacillus bacteria, will be used in the development of topical formulations containing live bacteria, taking inspiration from nature to impart numerous benefits to skin and hair.
“The integration of Lactobio into our Advanced Research is highly complementary: L’Oréal’s strong scientific knowledge and technological advancements coupled with Lactobio’s best-in-class formulations using living organisms will significantly strengthen and accelerate our microbiome research dedicated to beauty,” said Anne Colonna, Global Head of Advanced Research of L’Oréal Groupe. “In joining forces, we aim to develop a new generation of cosmetics that will use cutting-edge innovations in the formulation process to provide science-based, precision probiotic and postbiotic products with new performance levels.”
